• Etanercept (BENEPALI)
    • Study proposals are currently being considered for support when related to:

      • Rheumatoid arthritis
      • Psoriatic arthritis
      • Adult axial spondyloarthritis, including ankylosing spondylitis and non-radiographic spondyloarthritis
      • Plaque psoriasis

      Established areas of research include:

      • Maintenance of response
      • Patient reported outcomes
      • Patient satisfaction
      • Healthcare resource utilization
      • Patient adherence / drug survival
      • Assessing and quantifying the NOCEBO effect
      • Healthcare resource utilization

      Please note that ONLY proposals from within the EU will be considered by Biogen.

      Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee that support will be awarded. 

  • Infliximab (FLIXABI)